Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-25-105876
Filing Date
2025-08-08
Accepted
2025-08-08 16:24:11
Documents
17
Effectiveness Date
2025-08-08

Document Format Files

Seq Description Document Type Size
1 S-8 srzn-20250808.htm S-8 198373
2 EX-5.1 srzn-ex5_1.htm EX-5.1 21670
3 EX-23.1 srzn-ex23_1.htm EX-23.1 5854
4 EX-99.1 srzn-ex99_1.htm EX-99.1 292108
5 EX-FILING FEES srzn_exfilingfees.htm   iXBRL EX-FILING FEES 31270
6 GRAPHIC img200110477_0.jpg GRAPHIC 81231
7 GRAPHIC img200110477_1.jpg GRAPHIC 81231
  Complete submission text file 0000950170-25-105876.txt   896819

Data Files

Seq Description Document Type Size
19 EXTRACTED XBRL INSTANCE DOCUMENT srzn_exfilingfees_htm.xml XML 6505
Mailing Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-475-2820
Surrozen, Inc./DE (Filer) CIK: 0001824893 (see all company filings)

EIN.: 301374889 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-289432 | Film No.: 251198768
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)